[
  {
    "title": "10 Best Low Volatility ETFs To Buy",
    "published": 1713181738,
    "posting_price": 123.04320168,
    "close_price": 122.5575943,
    "percent_change": -0.39466413
  },
  {
    "title": "Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead",
    "published": 1713174360,
    "posting_price": 123.04320168,
    "close_price": 122.5575943,
    "percent_change": -0.39466413
  },
  {
    "title": "7 A-Rated Aggressive Biotech Stocks to Bet On in 2024",
    "published": 1712918400,
    "posting_price": 123.38312661,
    "close_price": 122.12054443,
    "percent_change": -1.02330214
  },
  {
    "title": "Biogen Is Suffering From Doubts About the Future",
    "published": 1712908860,
    "posting_price": 123.38312661,
    "close_price": 122.12054443,
    "percent_change": -1.02330214
  },
  {
    "title": "GLOBAL BROKER RATINGS: JPMorgan raises Persimmon, BoA raises Nike",
    "published": 1712906940,
    "posting_price": 123.38312661,
    "close_price": 122.12054443,
    "percent_change": -1.02330214
  },
  {
    "title": "Merck & Company: Balancing Growth Prospects Against Rising Operational Challenges",
    "published": 1712894820,
    "posting_price": 123.38312661,
    "close_price": 122.12054443,
    "percent_change": -1.02330214
  },
  {
    "title": "Merck & Co., Inc.'s (NYSE:MRK) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?",
    "published": 1712844048,
    "posting_price": 122.90723281,
    "close_price": 122.51874542,
    "percent_change": -0.3160818
  },
  {
    "title": "Declining COVID-19 Vaccine Sales Pinches Moderna, Pauses Kenya Vaccine Plant Plans",
    "published": 1712831100,
    "posting_price": 122.90723281,
    "close_price": 122.51874542,
    "percent_change": -0.3160818
  },
  {
    "title": "Cardinal Health, Cigna, Merck among top healthcare Quant picks ahead of Q1 earnings",
    "published": 1712828340,
    "posting_price": 122.90723281,
    "close_price": 122.51874542,
    "percent_change": -0.3160818
  },
  {
    "title": "The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today",
    "published": 1712825520,
    "posting_price": 122.90723281,
    "close_price": 122.51874542,
    "percent_change": -0.3160818
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Merck & Co",
    "published": 1712799300,
    "posting_price": 122.90723281,
    "close_price": 122.51874542,
    "percent_change": -0.3160818
  },
  {
    "title": "Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study",
    "published": 1712761140,
    "posting_price": 122.23709798,
    "close_price": 123.10147858,
    "percent_change": 0.70713443
  },
  {
    "title": "Company News for Apr 10, 2024",
    "published": 1712755500,
    "posting_price": 122.23709798,
    "close_price": 123.10147858,
    "percent_change": 0.70713443
  },
  {
    "title": "MRK December 2026 Options Begin Trading",
    "published": 1712743860,
    "posting_price": 122.23709798,
    "close_price": 123.10147858,
    "percent_change": 0.70713443
  },
  {
    "title": "The Pharmaceutical Industry Finds Itself At A Historical Crossroads",
    "published": 1712742780,
    "posting_price": 122.23709798,
    "close_price": 123.10147858,
    "percent_change": 0.70713443
  },
  {
    "title": "Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says",
    "published": 1712713620,
    "posting_price": 122.23709798,
    "close_price": 123.10147858,
    "percent_change": 0.70713443
  },
  {
    "title": "Moderna stock climbs 8% amid head/neck cancer vaccine data",
    "published": 1712658480,
    "posting_price": 122.93637444,
    "close_price": 123.0626297,
    "percent_change": 0.10269968
  },
  {
    "title": "Upcoming Catalysts Position Perrigo For Sustained Long-Term Dividend Growth",
    "published": 1712641773,
    "posting_price": 122.93637444,
    "close_price": 123.0626297,
    "percent_change": 0.10269968
  },
  {
    "title": "Golden Years Gainers: 3 Stocks to Fund Your Dream Retirement",
    "published": 1712599200,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "Merck price target raised by $3 at Berenberg, here's why",
    "published": 1712567220,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "Merck price target raised to $146 from $140 at Berenberg",
    "published": 1712551380,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "Moderna Stock (NASDAQ:MRNA): This mRNA Tech Pioneer Has Rebound Potential",
    "published": 1712540580,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024",
    "published": 1712512800,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "Morgan Stanley sees Fed rate cut fueling biotech stocks",
    "published": 1712493540,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "Morgan Stanley sees Fed rate cut fueling biotech stock performance",
    "published": 1712493180,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "Citi's top recommended large-cap stocks",
    "published": 1712452440,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "10 Best Weight Loss Drug Stocks to Buy Now",
    "published": 1712450873,
    "posting_price": 123.96585251,
    "close_price": 122.91693878,
    "percent_change": -0.84613118
  },
  {
    "title": "The three-year decline in earnings for Merck NYSE:MRK) isn't encouraging, but shareholders are still up 93% over that period",
    "published": 1712408476,
    "posting_price": 123.96584482,
    "close_price": 122.91693115,
    "percent_change": -0.84613118
  },
  {
    "title": "Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing",
    "published": 1712353519,
    "posting_price": 123.97556142,
    "close_price": 124.30577087,
    "percent_change": 0.26635044
  },
  {
    "title": "BME: Trading At A Historical Discount To NAV",
    "published": 1712317631,
    "posting_price": 123.97556142,
    "close_price": 124.30577087,
    "percent_change": 0.26635044
  },
  {
    "title": "Merck & Company (MRK) Receives a Buy from Cantor Fitzgerald",
    "published": 1712315760,
    "posting_price": 123.97556142,
    "close_price": 124.30577087,
    "percent_change": 0.26635044
  },
  {
    "title": "Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA for First-Line Treatment of Certain Patients with Metastatic Non-Small Cell Lung Cancer",
    "published": 1712311010,
    "posting_price": 123.97556142,
    "close_price": 124.30577087,
    "percent_change": 0.26635044
  },
  {
    "title": "10 Health Care Stocks Whale Activity In Today's Session",
    "published": 1712234280,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck puts KRAS cancer drug competitor to the test",
    "published": 1712230680,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Piper Sandler pharmaceuticals analysts hold an analyst/industry conference call",
    "published": 1712229060,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA\u00ae (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer",
    "published": 1712227500,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck: launches phase III trial in lung cancer",
    "published": 1712219581,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck to test lung cancer combo therapy in late-stage trial",
    "published": 1712215920,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck starts phase 3 MK-1084 trial for lung cancer treatment",
    "published": 1712215800,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck initiates Phase 3 clinical trial of MK-1084",
    "published": 1712209740,
    "posting_price": 127.06403199,
    "close_price": 123.9852829,
    "percent_change": -2.42299024
  },
  {
    "title": "Merck (MRK) Stock Sinks As Market Gains: What You Should Know",
    "published": 1712181019,
    "posting_price": 126.59784798,
    "close_price": 126.16078949,
    "percent_change": -0.34523374
  },
  {
    "title": "3 Dow Jones Stocks For Your April 2024 Watch List",
    "published": 1712154826,
    "posting_price": 126.59784798,
    "close_price": 126.16078949,
    "percent_change": -0.34523374
  },
  {
    "title": "Bristol Myers wins label expansion for anemia therapy in EU",
    "published": 1712146200,
    "posting_price": 126.59784798,
    "close_price": 126.16078949,
    "percent_change": -0.34523374
  },
  {
    "title": "REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients with Platinum-Resistant Ovarian Cancer",
    "published": 1712145600,
    "posting_price": 126.59784798,
    "close_price": 126.16078949,
    "percent_change": -0.34523374
  },
  {
    "title": "Daiichi, Merck announce first patient dosed in ovarian cancer trial",
    "published": 1712139180,
    "posting_price": 126.59784798,
    "close_price": 126.16078949,
    "percent_change": -0.34523374
  },
  {
    "title": "Merck: 1st patient in raludotatug study",
    "published": 1712137346,
    "posting_price": 126.59784798,
    "close_price": 126.16078949,
    "percent_change": -0.34523374
  },
  {
    "title": "Merck: We Were Wrong, But The Exuberance Is Overly Done Here (Rating Upgrade)",
    "published": 1712134800,
    "posting_price": 126.59784798,
    "close_price": 126.16078949,
    "percent_change": -0.34523374
  },
  {
    "title": "Daiichi Sankyo, Merck announe first patient dosed in REJOICE-Ovarian01 trial",
    "published": 1712128320,
    "posting_price": 126.59784798,
    "close_price": 126.16078949,
    "percent_change": -0.34523374
  },
  {
    "title": "Market Whales and Their Recent Bets on MRK Options",
    "published": 1712116260,
    "posting_price": 126.59784798,
    "close_price": 126.16078949,
    "percent_change": -0.34523374
  },
  {
    "title": "Merck: Better Times Ahead On Approvals And Outlook",
    "published": 1712075977,
    "posting_price": 126.35505092,
    "close_price": 126.59785461,
    "percent_change": 0.19215986
  },
  {
    "title": "Cantor Fitzgerald Remains a Buy on Merck & Company (MRK)",
    "published": 1712028360,
    "posting_price": 126.35505092,
    "close_price": 126.59785461,
    "percent_change": 0.19215986
  },
  {
    "title": "Russell 2000 Index Best And Worst Performing Stocks Of 2024",
    "published": 1712020200,
    "posting_price": 126.35505092,
    "close_price": 126.59785461,
    "percent_change": 0.19215986
  },
  {
    "title": "Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript",
    "published": 1714481062,
    "posting_price": 127.15144372,
    "close_price": 125.50038147,
    "percent_change": -1.29850059
  },
  {
    "title": "FTC expands patent listing challenges for drugs",
    "published": 1714468440,
    "posting_price": 127.15144372,
    "close_price": 125.50038147,
    "percent_change": -1.29850059
  },
  {
    "title": "Buy Rating Affirmed on Merck & Company Following Strong Q1 Performance and Upbeat Full-Year Guidance",
    "published": 1714439220,
    "posting_price": 127.15144372,
    "close_price": 125.50038147,
    "percent_change": -1.29850059
  },
  {
    "title": "Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults",
    "published": 1714395600,
    "posting_price": 127.92841556,
    "close_price": 126.37446594,
    "percent_change": -1.21470247
  },
  {
    "title": "Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week",
    "published": 1714395360,
    "posting_price": 127.92841556,
    "close_price": 126.37446594,
    "percent_change": -1.21470247
  },
  {
    "title": "Merck late-stage data strengthens profile of pneumonia vaccine candidate",
    "published": 1714382580,
    "posting_price": 127.92841556,
    "close_price": 126.37446594,
    "percent_change": -1.21470247
  },
  {
    "title": "Novo Nordisk: Growth Is Still A Better Choice",
    "published": 1714377660,
    "posting_price": 127.92841556,
    "close_price": 126.37446594,
    "percent_change": -1.21470247
  },
  {
    "title": "TECB: Not A Good Choice When Compared To Other Traditional Technology ETFs",
    "published": 1714372333,
    "posting_price": 127.92841556,
    "close_price": 126.37446594,
    "percent_change": -1.21470247
  },
  {
    "title": "Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates",
    "published": 1714273200,
    "posting_price": 127.92841556,
    "close_price": 126.37446594,
    "percent_change": -1.21470247
  },
  {
    "title": "Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think",
    "published": 1714220687,
    "posting_price": 127.92841556,
    "close_price": 126.37446594,
    "percent_change": -1.21470247
  },
  {
    "title": "Diving Into Deciphera Pharmaceuticals",
    "published": 1714147000,
    "posting_price": 126.38419343,
    "close_price": 127.42338562,
    "percent_change": 0.82224854
  },
  {
    "title": "Interesting MRK Put And Call Options For June 7th",
    "published": 1714126500,
    "posting_price": 126.38419343,
    "close_price": 127.42338562,
    "percent_change": 0.82224854
  },
  {
    "title": "Merck price target raised by $15 at BofA, here's why",
    "published": 1714119960,
    "posting_price": 126.38419343,
    "close_price": 127.42338562,
    "percent_change": 0.82224854
  },
  {
    "title": "Merck price target raised by $5 at Wells Fargo, here's why",
    "published": 1714116000,
    "posting_price": 126.38419343,
    "close_price": 127.42338562,
    "percent_change": 0.82224854
  },
  {
    "title": "Merck & Company: A Strong Buy on Robust Performance and Future Growth Prospects",
    "published": 1714115820,
    "posting_price": 126.38419343,
    "close_price": 127.42338562,
    "percent_change": 0.82224854
  },
  {
    "title": "Merck & Co. Outperforms with Strong Keytruda Sales and Raised Guidance: A Buy Rating Affirmed",
    "published": 1714112760,
    "posting_price": 126.38419343,
    "close_price": 127.42338562,
    "percent_change": 0.82224854
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Globus Medical (GMED) and Merck & Company (MRK)",
    "published": 1714109460,
    "posting_price": 126.38419343,
    "close_price": 127.42338562,
    "percent_change": 0.82224854
  },
  {
    "title": "Merck & Company (MRK) Gets a Buy from Barclays",
    "published": 1714103340,
    "posting_price": 126.38419343,
    "close_price": 127.42338562,
    "percent_change": 0.82224854
  },
  {
    "title": "Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points",
    "published": 1714097040,
    "posting_price": 126.38419343,
    "close_price": 127.42338562,
    "percent_change": 0.82224854
  },
  {
    "title": "Merck (MRK) Q1 2024 Earnings Call Transcript",
    "published": 1714073412,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook",
    "published": 1714069741,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "These Are The Biotechs Showing Up At The Biggest Cancer Meeting Of The Year (Oral Presentations)",
    "published": 1714067356,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales",
    "published": 1714061340,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma",
    "published": 1714059724,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "20 Fastest Growing Health Tech Companies in the World",
    "published": 1714059264,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck raises 2024 guidance on cancer drug demand",
    "published": 1714058613,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck & Co., Inc. (MRK) Q1 2024 Earnings Call Transcript",
    "published": 1714054529,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda",
    "published": 1714050780,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck Shares Climb After Higher-Than-Expected Sales of Cancer Drug Keytruda",
    "published": 1714050780,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "We Think Merck (NYSE:MRK) Can Stay On Top Of Its Debt",
    "published": 1714050017,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?",
    "published": 1714048680,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "What You Missed On Wall Street This Morning",
    "published": 1714043400,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "S&P 500 Down Over 1%; Merck Increases 2024 Outlook",
    "published": 1714043400,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "UPDATE 3-Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda",
    "published": 1714043058,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda",
    "published": 1714041183,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck raises 2024 profit forecast on strong cancer, HPV drugs sales",
    "published": 1714041000,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck Announces First-Quarter 2024 Financial Results",
    "published": 1714041000,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "MRK Stock Earnings: Merck & Co Beats EPS, Beats Revenue for Q1 2024",
    "published": 1714039140,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Meta Falls 15% On Great Earnings, Tesla Rises 12% On Ugly Earnings \u2013 Here Is The Real Reason",
    "published": 1714039020,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck raises annual target ranges",
    "published": 1714031860,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Fly Intel: Pre-market Movers",
    "published": 1714031580,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck & Co raises annual outlook thanks to first quarter boost",
    "published": 1714029180,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Bristol-Myers posts Q1 beat despite growth headwinds",
    "published": 1714028460,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck: Q1 Earnings Snapshot",
    "published": 1714027515,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck KGaA lays cornerstone for research centre in Darmstadt",
    "published": 1714027500,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "MRK Earnings: Merck Delivers Q1 Earnings Beat",
    "published": 1714027380,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck raises guidance as Keytruda sales jump 20% in Q1",
    "published": 1714025640,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Options Volatility and Implied Earnings Moves Today, April 25, 2024",
    "published": 1714025160,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck in charts: Pharmaceutical segment soars on KEYTRUDA, GARDASIL strength in Q1",
    "published": 1714024980,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck Non-GAAP EPS of $2.07 beats by $0.15, revenue of $15.8B beats by $600M",
    "published": 1714023480,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck\u2019s first-quarter results beat expectations amid healthy vaccine-sales growth",
    "published": 1714023240,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck raises FY24 adjusted EPS view to $8.53-$8.65 from $8.44-$8.59",
    "published": 1714023120,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck reports Q1 adjusted EPS $2.07, consensus $1.87",
    "published": 1714023060,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst",
    "published": 1714022580,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "APA Corp Leads Smead Value Fund's Q1 2024 Portfolio Adjustments with 0.68% Impact",
    "published": 1714021260,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Analysts Conflicted on These Healthcare Names: Travere Therapeutics (TVTX), Humana (HUM) and Merck & Company (MRK)",
    "published": 1714020660,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
    "published": 1714016400,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "What You Missed On Wall Street On Thursday",
    "published": 1714015800,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Merck price target raised by $1 at Truist, here's why",
    "published": 1714011000,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Marks Electrical CFO Rebalances Share Portfolio",
    "published": 1714010580,
    "posting_price": 125.95684147,
    "close_price": 126.95719147,
    "percent_change": 0.79420061
  },
  {
    "title": "Alphabet, Microsoft, Southwest earnings: What to watch",
    "published": 1713995448,
    "posting_price": 123.16944985,
    "close_price": 123.3442688,
    "percent_change": 0.14193369
  },
  {
    "title": "4 Large Drug Stocks to Hold on to Amid Industry Challenges",
    "published": 1713967740,
    "posting_price": 123.16944985,
    "close_price": 123.3442688,
    "percent_change": 0.14193369
  },
  {
    "title": "Merck Q1 Earnings Preview: Strong quarter expectations on the back of core products' growth",
    "published": 1713949620,
    "posting_price": 123.16944985,
    "close_price": 123.3442688,
    "percent_change": 0.14193369
  },
  {
    "title": "Notable companies reporting before tomorrow's open",
    "published": 1713943500,
    "posting_price": 123.16944985,
    "close_price": 123.3442688,
    "percent_change": 0.14193369
  },
  {
    "title": "Immutep reports promising efti/Keytruda data for head and neck cancer",
    "published": 1713928380,
    "posting_price": 123.16944985,
    "close_price": 123.3442688,
    "percent_change": 0.14193369
  },
  {
    "title": "Investor Alert: Prepare for the Market Crash With These 3 Stocks",
    "published": 1713906698,
    "posting_price": 124.41262814,
    "close_price": 123.22773743,
    "percent_change": -0.95238781
  },
  {
    "title": "3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge",
    "published": 1713898800,
    "posting_price": 124.41262814,
    "close_price": 123.22773743,
    "percent_change": -0.95238781
  },
  {
    "title": "ImmunityBio: FDA Approval Gets Ball Rolling Towards Next Set Of Indications",
    "published": 1713876036,
    "posting_price": 124.41262814,
    "close_price": 123.22773743,
    "percent_change": -0.95238781
  },
  {
    "title": "Here\u2019s Why Merck & Co. (MRK) Outperformed in Q1",
    "published": 1713872968,
    "posting_price": 124.41262814,
    "close_price": 123.22773743,
    "percent_change": -0.95238781
  },
  {
    "title": "ImmunityBio Lights Up: Anktiva's FDA Nod Shakes Up Bladder Cancer Battle",
    "published": 1713872716,
    "posting_price": 124.41262814,
    "close_price": 123.22773743,
    "percent_change": -0.95238781
  },
  {
    "title": "Baron Health Care Fund Q1 2024 Shareholder Letter",
    "published": 1713864600,
    "posting_price": 124.41262814,
    "close_price": 123.22773743,
    "percent_change": -0.95238781
  },
  {
    "title": "Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern?",
    "published": 1713862803,
    "posting_price": 124.41262814,
    "close_price": 123.22773743,
    "percent_change": -0.95238781
  },
  {
    "title": "Looking Into Merck & Co's Recent Short Interest",
    "published": 1713862080,
    "posting_price": 124.41262814,
    "close_price": 123.22773743,
    "percent_change": -0.95238781
  },
  {
    "title": "Takeda Pharmaceutical: A Long-Term Cash Cow",
    "published": 1713859260,
    "posting_price": 124.41262814,
    "close_price": 123.22773743,
    "percent_change": -0.95238781
  },
  {
    "title": "How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?",
    "published": 1713811140,
    "posting_price": 123.06262807,
    "close_price": 123.28601074,
    "percent_change": 0.1815195
  },
  {
    "title": "10 Best Performing Biotech ETFs in 2024",
    "published": 1713798659,
    "posting_price": 123.06262807,
    "close_price": 123.28601074,
    "percent_change": 0.1815195
  },
  {
    "title": "Hookipa Pharma: 04/25/24 Update Should Be The First Of Several Positive Catalysts",
    "published": 1713795623,
    "posting_price": 123.06262807,
    "close_price": 123.28601074,
    "percent_change": 0.1815195
  },
  {
    "title": "Options Volatility and Implied Earnings Moves This Week, April 22 \u2013 April 26, 2024",
    "published": 1713765720,
    "posting_price": 123.06262807,
    "close_price": 123.28601074,
    "percent_change": 0.1815195
  },
  {
    "title": "Top high growth investment ratio stocks from each sector - GS",
    "published": 1713756360,
    "posting_price": 123.06262807,
    "close_price": 123.28601074,
    "percent_change": 0.1815195
  },
  {
    "title": "3 Under-The-Radar Stocks With Positive Potential",
    "published": 1713699780,
    "posting_price": 123.06262807,
    "close_price": 123.28601074,
    "percent_change": 0.1815195
  },
  {
    "title": "Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 78%",
    "published": 1713697233,
    "posting_price": 123.06262807,
    "close_price": 123.28601074,
    "percent_change": 0.1815195
  },
  {
    "title": "Earnings week ahead: Tesla, Meta Platforms, Google, Microsoft, Intel, Exxon Mobil, and more",
    "published": 1713683100,
    "posting_price": 123.06262807,
    "close_price": 123.28601074,
    "percent_change": 0.1815195
  },
  {
    "title": "Wall Street Breakfast: The Week Ahead",
    "published": 1713682002,
    "posting_price": 123.06262807,
    "close_price": 123.28601074,
    "percent_change": 0.1815195
  },
  {
    "title": "Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week",
    "published": 1713674940,
    "posting_price": 123.06262807,
    "close_price": 123.28601074,
    "percent_change": 0.1815195
  },
  {
    "title": "Goldman picks top capex and R&D stocks",
    "published": 1713663840,
    "posting_price": 123.06262807,
    "close_price": 123.28601074,
    "percent_change": 0.1815195
  },
  {
    "title": "THQ: Collecting A High Yield From Increased Medical Spending",
    "published": 1713614580,
    "posting_price": 123.06262046,
    "close_price": 123.28600311,
    "percent_change": 0.1815195
  },
  {
    "title": "Sellas Life Sciences Group: A Lottery Ticket With An Estimated 9x Payout",
    "published": 1713534583,
    "posting_price": 122.03313806,
    "close_price": 122.15939331,
    "percent_change": 0.10345981
  },
  {
    "title": "Merck garners Canadian approval for Keytruda in first-line gastroesophageal cancer",
    "published": 1713524880,
    "posting_price": 122.03313806,
    "close_price": 122.15939331,
    "percent_change": 0.10345981
  },
  {
    "title": "Health Canada Approves KEYTRUDA\u00ae as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-containing chemotherapy",
    "published": 1713524640,
    "posting_price": 122.03313806,
    "close_price": 122.15939331,
    "percent_change": 0.10345981
  },
  {
    "title": "Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth",
    "published": 1713510228,
    "posting_price": 122.03313806,
    "close_price": 122.15939331,
    "percent_change": 0.10345981
  },
  {
    "title": "Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks",
    "published": 1713492120,
    "posting_price": 122.03313806,
    "close_price": 122.15939331,
    "percent_change": 0.10345981
  },
  {
    "title": "13 Best Low Volatility Stocks to Buy According to Hedge Funds",
    "published": 1713472023,
    "posting_price": 121.90687464,
    "close_price": 121.62522888,
    "percent_change": -0.23103353
  },
  {
    "title": "Cantor Fitzgerald Reaffirms Their Buy Rating on Merck & Company (MRK)",
    "published": 1713439560,
    "posting_price": 121.90687464,
    "close_price": 121.62522888,
    "percent_change": -0.23103353
  },
  {
    "title": "Marks Electric agrees extension of headquarters' lease in Leicester",
    "published": 1713426360,
    "posting_price": 121.90687464,
    "close_price": 121.62522888,
    "percent_change": -0.23103353
  },
  {
    "title": "Marks Electrical Secures New Lease Agreement",
    "published": 1713421080,
    "posting_price": 121.90687464,
    "close_price": 121.62522888,
    "percent_change": -0.23103353
  },
  {
    "title": "Unveiling 17 Analyst Insights On Merck & Co",
    "published": 1713402240,
    "posting_price": 121.90687464,
    "close_price": 121.62522888,
    "percent_change": -0.23103353
  },
  {
    "title": "Merck Earnings Preview: Not Much To Fear, Plenty To Look Forward To",
    "published": 1713369122,
    "posting_price": 122.05256759,
    "close_price": 121.76120758,
    "percent_change": -0.23871682
  },
  {
    "title": "Coming FDA Approvals Could Send These 3 Drug Stocks Soaring",
    "published": 1713355200,
    "posting_price": 122.05256759,
    "close_price": 121.76120758,
    "percent_change": -0.23871682
  },
  {
    "title": "Merck Insiders Sold US$15m Of Shares Suggesting Hesitancy",
    "published": 1713351640,
    "posting_price": 122.05256759,
    "close_price": 121.76120758,
    "percent_change": -0.23871682
  },
  {
    "title": "Merck Manuals Celebrates Its 125th Year",
    "published": 1713347926,
    "posting_price": 122.05256759,
    "close_price": 121.76120758,
    "percent_change": -0.23871682
  },
  {
    "title": "GreensKeeper Value Fund Q1 2024 Letter",
    "published": 1713342600,
    "posting_price": 122.05256759,
    "close_price": 121.76120758,
    "percent_change": -0.23871682
  },
  {
    "title": "MilliporeSigma Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour",
    "published": 1713340800,
    "posting_price": 122.05256759,
    "close_price": 121.76120758,
    "percent_change": -0.23871682
  },
  {
    "title": "Market Whales and Their Recent Bets on MRK Options",
    "published": 1713324120,
    "posting_price": 122.05256759,
    "close_price": 121.76120758,
    "percent_change": -0.23871682
  },
  {
    "title": "3 Dow Stocks to Buy Now: Q2 Edition",
    "published": 1713295028,
    "posting_price": 122.91694336,
    "close_price": 121.46012115,
    "percent_change": -1.18520862
  },
  {
    "title": "FHLC: Healthcare Dashboard For April",
    "published": 1713284682,
    "posting_price": 122.91694336,
    "close_price": 121.46012115,
    "percent_change": -1.18520862
  },
  {
    "title": "As more rare disease therapies launch, their prices are rising",
    "published": 1713266880,
    "posting_price": 122.91694336,
    "close_price": 121.46012115,
    "percent_change": -1.18520862
  },
  {
    "title": "MilliporeSigma Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing",
    "published": 1713254400,
    "posting_price": 122.91694336,
    "close_price": 121.46012115,
    "percent_change": -1.18520862
  }
]